S&P 500 7,666.45 +0.19%
Nasdaq 26,871.60 +0.04%
S&P/TSX 35,154.76 −0.23%
Apple 330.32 −0.81%
Nvidia 230.86 +1.09%
Microsoft 512.80 −0.02%
Shopify 212.10 +0.56%
Royal Bank 277.86 −0.74%
CAD/USD 0.7035 +0.15%
CLOSED · 01:05 ET
Market ClerkRecap
Fri Oct 2 · markets closed3 signals on Oct 1308 insider buys this week · $10330.5BCIRO short report next: Oct 14The week ahead
MN
INSIDER · KYMR · Kymera Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Mainolfi Nello

Every open-market transaction filed under this name, Oct 1 to Oct 1.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$3.4M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell262$116.12$30K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell8,230$115.40$950K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell7,601$114.43$870K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell4,876$113.24$552K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell5,506$112.42$619K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell3,525$111.44$393K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.